NASDAQ | ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index.
The Biotech Index includes common stocks and depositary receipts ofU. S. exchange-listed companies in the biotechnology industry.
Such companies may include medium-capitalization companies and foreign companies that are listed on aU. S. exchange.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 16.49% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 13.29% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 11.05% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 5.51% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.48% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.41% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.36% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.76% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.53% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 3.11% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.97% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.91% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.84% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.65% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.62% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 2.34% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.23% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.91% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 1.83% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.73% |